TABLE 2.
In vitro activities of fluoroquinolones against 187 Korean C. difficile isolates according to toxigenic status
Toxin status (no. of isolates tested) | Antimicrobial agent | MIC (μg/ml)
|
||
---|---|---|---|---|
Range | MIC50 | MIC90 | ||
A+ B+ (115) | Norfloxacin | 16-256 | 64 | 128 |
Ciprofloxacin | 4-128 | 16 | 32 | |
Ofloxacin | 8-256 | 64 | 128 | |
Levofloxacin | 2-128 | 32 | 64 | |
Gatifloxacin | 1-32 | 8 | 8 | |
Moxifloxacin | 1-16 | 8 | 8 | |
A− B+ (31) | Norfloxacin | 32-128 | 64 | 128 |
Ciprofloxacin | 8-64 | 32 | 32 | |
Ofloxacin | 8-256 | 128 | 256 | |
Levofloxacin | 4-128 | 64 | 128 | |
Gatifloxacin | 1-32 | 32 | 32 | |
Moxifloxacin | 1-32 | 32 | 32 | |
A− B− (41) | Norfloxacin | 32-128 | 32 | 64 |
Ciprofloxacin | 4-32 | 8 | 8 | |
Ofloxacin | 8-256 | 8 | 8 | |
Levofloxacin | 4-128 | 4 | 4 | |
Gatifloxacin | 1-32 | 1 | 2 | |
Moxifloxacin | 1-16 | 1 | 2 |